D. van der Heijde

Active 1989–2021

Also published as
D van der Heijde
68
Papers
23,926
Citations
67
h-index
68
i10-index

Citations

Citations per year for D. van der Heijde1987: 2 citations1990: 1 citations1991: 1 citations1992: 5 citations1993: 2 citations1994: 3 citations1995: 4 citations1996: 4 citations1997: 6 citations1998: 8 citations1999: 12 citations2000: 15 citations2001: 32 citations2002: 54 citations2003: 67 citations2004: 91 citations2005: 164 citations2006: 162 citations2007: 181 citations2008: 196 citations2009: 211 citations2010: 219 citations2011: 324 citations2012: 242 citations2013: 284 citations2014: 214 citations2015: 221 citations2016: 188 citations2017: 150 citations2018: 135 citations2019: 584 citations2020: 578 citations2021: 359 citations2022: 304 citations2023: 149 citations2024: 344 citations2025: 98 citations2026: 3 citations1988–1989: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 1,363 citing papers, 15.2% of this breakdownUnited Kingdom: 795 citing papers, 8.8% of this breakdownNetherlands: 765 citing papers, 8.5% of this breakdownGermany: 667 citing papers, 7.4% of this breakdownFrance: 509 citing papers, 5.7% of this breakdownCanada: 456 citing papers, 5.1% of this breakdownItaly: 362 citing papers, 4% of this breakdownSpain: 290 citing papers, 3.2% of this breakdownBelgium: 269 citing papers, 3% of this breakdownAustralia: 262 citing papers, 2.9% of this breakdownDenmark: 252 citing papers, 2.8% of this breakdownChina: 250 citing papers, 2.8% of this breakdown
0%15.2%Other 30.6%

Fields

  • Medicine90.1%
  • Biochemistry, Genetics and Molecular Biology3.9%
  • Immunology and Microbiology2%
  • Health Professions0.9%
  • Economics, Econometrics and Finance0.6%
  • Neuroscience0.5%
  • Other2%

Topics

  • Rheumatoid Arthritis Research and Therapies19.6%
  • Spondyloarthritis Studies and Treatments14.5%
  • Osteoarthritis Treatment and Mechanisms5.3%
  • Autoimmune and Inflammatory Disorders Research5.2%
  • Psoriasis: Treatment and Pathogenesis3.8%
  • Total Knee Arthroplasty Outcomes3%
  • Other48.6%

Coauthors

All papers

Open in search
  1. The Assessment of SpondyloArthritis international Society classification criteria for peripheral spondyloarthritis and for spondyloarthritis in general

    Authors: , , , , , , , , , , , , , , , , , , - Annals of the Rheumatic Diseases 2010 cited by 1,733

  2. Treating rheumatoid arthritis to target: recommendations of an international task force

    Authors: , , , , , , , , , , , , , , , , , , , , , - Annals of the Rheumatic Diseases 2010 cited by 2,097

  3. Evaluation of clinically relevant changes in patient reported outcomes in knee and hip osteoarthritis: the minimal clinically important improvement

    Authors: , , , , , , , , , , - Annals of the Rheumatic Diseases 2004 cited by 1,096

  4. OMERACT-OARSI Initiative: Osteoarthritis Research Society International set of responder criteria for osteoarthritis clinical trials revisited.

    Authors: , , , , , , , , , - Osteoarthritis and Cartilage 2004 cited by 854

  5. How to read radiographs according to the Sharp/van der Heijde method.

    Authors: - 1999 cited by 1,152

  6. Evaluation of clinically relevant states in patient reported outcomes in knee and hip osteoarthritis: the patient acceptable symptom state

    Authors: , , , , , , , , , , - Annals of the Rheumatic Diseases 2004 cited by 630

  7. Minimum clinically important improvement and patient acceptable symptom state in pain and function in rheumatoid arthritis, ankylosing spondylitis, chronic back pain, hand osteoarthritis, and hip and knee osteoarthritis: Results from a prospective multinational study

    Authors: , , , , , , , , , , , , , - Arthritis Care & Research 2012 cited by 420

  8. New criteria for inflammatory back pain in patients with chronic back pain: a real patient exercise by experts from the Assessment of SpondyloArthritis international Society (ASAS)

    Authors: , , , , , , , , , , , , , , - Annals of the Rheumatic Diseases 2009 cited by 642

  9. 2010 update of the ASAS/EULAR recommendations for the management of ankylosing spondylitis

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , - Annals of the Rheumatic Diseases 2011 cited by 981

  10. Assessment of enthesitis in ankylosing spondylitis

    Authors: , , , , , , , - Annals of the Rheumatic Diseases 2003 cited by 682

  11. Long-term safety of methotrexate monotherapy in patients with rheumatoid arthritis: a systematic literature research

    Authors: , - Annals of the Rheumatic Diseases 2008 cited by 671

  12. Multinational evidence-based recommendations for the use of methotrexate in rheumatic disorders with a focus on rheumatoid arthritis: integrating systematic literature research and expert opinion of a broad international panel of rheumatologists in the 3E Initiative

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , - Annals of the Rheumatic Diseases 2008 cited by 491

  13. How to diagnose axial spondyloarthritis early

    Authors: , , , , - Annals of the Rheumatic Diseases 2004 cited by 665

  14. Study of active controlled monotherapy used for rheumatoid arthritis, an IL-6 inhibitor (SAMURAI): evidence of clinical and radiographic benefit from an x ray reader-blinded randomised controlled trial of tocilizumab

    Authors: , , , , , , , , - Annals of the Rheumatic Diseases 2007 cited by 741

  15. Both structural damage and inflammation of the spine contribute to impairment of spinal mobility in patients with ankylosing spondylitis

    Authors: , , , , , - Annals of the Rheumatic Diseases 2010 cited by 299

  16. ASAS/EULAR recommendations for the management of ankylosing spondylitis

    Authors: , , , , , , , , , , , , , , , , , , , , , - Annals of the Rheumatic Diseases 2005 cited by 704

  17. Development of the ASQoL: a quality of life instrument specific to ankylosing spondylitis

    Authors: , , , , , , , , , - Annals of the Rheumatic Diseases 2002 cited by 598

  18. Observed Incidence of Uveitis Following Certolizumab Pegol Treatment in Patients With Axial Spondyloarthritis

    Authors: , , , , , , , , , , - Arthritis Care & Research 2016 cited by 114

  19. Deciding on progression of joint damage in paired films of individual patients: smallest detectable difference or change

    Authors: , , , , - Annals of the Rheumatic Diseases 2004 cited by 292

  20. Radiographic assessment of sacroiliitis by radiologists and rheumatologists: does training improve quality?

    Authors: , , , , , , , - Annals of the Rheumatic Diseases 2003 cited by 235

  21. Reliability and sensitivity to change of a simplification of the Sharp/van der Heijde radiological assessment in rheumatoid arthritis

    Authors: , , , , - Lara D. Veeken 1999 cited by 225

  22. Reporting disease activity in clinical trials of patients with rheumatoid arthritis: EULAR/ACR collaborative recommendations

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Steven C. Vlad, Ronald van Vollenhoven, Michael M. Ward, Michael E. Weinblatt, George A. Wells, Barbara White, Frederick Wolfe, B Zhang, A. Zink, David T. Felson - Annals of the Rheumatic Diseases 2008 cited by 224

  23. Psoriatic arthritis imaging: a review of scoring methods

    Authors: , , , - Annals of the Rheumatic Diseases 2005 cited by 170

  24. Evidence of radiographic benefit of treatment with infliximab plus methotrexate in rheumatoid arthritis patients who had no clinical improvement: A detailed subanalysis of data from the anti–tumor necrosis factor trial in rheumatoid arthritis with concomitant therapy study

    Authors: , , , , , , , , , - Arthritis & Rheumatism 2005 cited by 462